Accelerated Approval of Cancer Drugs: How Many Verify Clinical Benefit?
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
Category: Policy
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
In the final quarter of 2023, the FDA issued 17 approvals specifically for the treatment of tumors.
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
In the beginning of his cancer journey, Edward Cutler felt unlucky. In 2012, he saw an ad suggesting that...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...